Recent legal proceedings against former FBI Director James Comey center on three federal matters brought during President Donald Trump’s second term. A 2025 indictment alleging false statements to Congress was dismissed in November 2025 after a judge ruled the interim U.S. attorney was improperly appointed. An April 2026 North Carolina indictment charging a threat to the president via a social media post has seen arraignment delayed until January 2027, with any trial likely extending into 2027. The October 2026 Washington, D.C., filing under the Espionage Act remains at the criminal information stage, faces statute-of-limitations challenges, requires grand-jury approval for an indictment, and is subject to dismissal motions. These procedural timelines and pending hurdles leave no realistic path to sentencing before the end of 2026, underpinning the market’s strong consensus.